{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T13:56:51Z","timestamp":1776434211628,"version":"3.51.2"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T00:00:00Z","timestamp":1530230400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s40292-018-0268-x","type":"journal-article","created":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T03:39:01Z","timestamp":1530243541000},"page":"295-301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Prevalence and Comorbidities of Resistant Hypertension: A Collaborative Population-Based Observational Study"],"prefix":"10.1007","volume":"25","author":[{"given":"Simone","family":"Romano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Idolazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano","family":"Fava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Fondrieschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Celebrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Delva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorella","family":"Branz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Donato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Dalbeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Minuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,29]]},"reference":[{"issue":"7","key":"268_CR1","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","volume":"31","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Red\u00f3n J, Zanchetti A, B\u00f6hm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Members Task Force. 2013 ESH\/ESC Guidelines for the management of arterial hypertension. J Hypertens. 2013;31(7):1281\u2013357.","journal-title":"J Hypertens"},{"issue":"6","key":"268_CR2","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","volume":"51","author":"DA Calhoun","year":"2008","unstructured":"Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51(6):1403\u201319.","journal-title":"Hypertension"},{"key":"268_CR3","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA, Williamson JD, Wright JT. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary. Hypertension. 2017;71(6):HYP.0000000000000066."},{"issue":"3","key":"268_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/heartjnl-2011-300741","volume":"98","author":"Robert H Fagard","year":"2011","unstructured":"Fagard RH. Resistant hypertension. Heart. 2012;98(3):254\u2013261.","journal-title":"Heart"},{"issue":"4","key":"268_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.rec.2013.09.027","volume":"67","author":"Teresa Gij\u00f3n-Conde","year":"2014","unstructured":"Gijon-Conde T, Graciani A, Banegas JR, Gij\u00c33n-Conde T, Graciani A, Banegas JR, Gijon-Conde T, Graciani A, Banegas JR. Resistant hypertension: demography and clinical characteristics in 6292 patients in a primary health care setting. Rev Esp Cardiol. 2014;67(4):270\u2013276.","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"issue":"6","key":"268_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1524-6175.2002.02045.x","volume":"4","author":"WC Cushman","year":"2002","unstructured":"Cushman WC, Ford CE, Cutler JA, Margolis KL, Davis BR, Grimm RH, Black HR, Hamilton BP, Holland J, Nwachuku C, Papademetriou V, Probstfield J, Wright JT, Alderman MH, Weiss RJ, Piller L, Bettencourt J, Walsh SM. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J. Clin. Hypertens. (Greenwich). 2002;4(6):393\u2013404.","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"issue":"11","key":"268_CR7","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/archinte.168.11.1159","volume":"168","author":"KK Gaddam","year":"2008","unstructured":"Gaddam KK, Nishizaka MK, Pratt-Ubunama MN, Pimenta E, Aban I, Oparil S, Calhoun DA. Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion. Arch Intern Med. 2008;168(11):1159\u201364.","journal-title":"Arch Intern Med"},{"issue":"10","key":"268_CR8","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/j.amjmed.2015.05.008","volume":"128","author":"S Romano","year":"2015","unstructured":"Romano S, Chacko SJ, Rangarajan V, Chung J, Farzaneh-Far A. Resistant Hypertension. Am J Med. 2015;128(10):e23\u20135.","journal-title":"Am J Med"},{"key":"268_CR9","doi-asserted-by":"crossref","unstructured":"Romano S, Fava C, Minuz P, Farzaneh-Far A. Succinate dehydrogenase gene mutation with cardiac paraganglioma: multimodality imaging and pathological correlation. Eur Heart J. 2017.","DOI":"10.1093\/eurheartj\/ehx007"},{"issue":"1","key":"268_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1056\/NEJM200101043440101","volume":"344","author":"FM Sacks","year":"2001","unstructured":"Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton DG, Karanja N, Lin PH, M. DASH-Sodium Collaborative Research Group, Most-Windhauser MM, Moore TJ, Proschan MA, Cutler JA. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344(1):3\u201310.","journal-title":"N Engl J Med"},{"issue":"3","key":"268_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1161\/01.HYP.0000200702.76436.4b","volume":"47","author":"EC Okonofua","year":"2006","unstructured":"Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertens. (Dallas, Tex. 1979. 2006;47(3):345\u201351.","journal-title":"Hypertens. (Dallas, Tex. 1979"},{"issue":"5","key":"268_CR12","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1161\/HYPERTENSIONAHA.110.168948","volume":"57","author":"A Sierra De La","year":"2011","unstructured":"De La Sierra A, Segura J, Banegas JR, Gorostidi M, De La Cruz JJ, Armario P, Oliveras A, Ruilope LM. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011;57(5):898\u2013902.","journal-title":"Hypertension"},{"issue":"12","key":"268_CR13","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/S0895-7061(01)02193-8","volume":"14","author":"MA Brown","year":"2001","unstructured":"Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens. 2001;14(12):1263\u20139.","journal-title":"Am J Hypertens"},{"issue":"28","key":"268_CR14","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, B\u00f6hm M, Christiaens T, Cifkova R, Wood DA, et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159\u2013219.","journal-title":"Eur Heart J"},{"issue":"12","key":"268_CR15","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/ajh\/hpt132","volume":"26","author":"SS Hayek","year":"2013","unstructured":"Hayek SS, Abdou MH, Demoss BD, Legaspi JMO, Veledar E, Deka A, Krishnan SK, Wilmot KA, Patel AD, Kumar VR, Devireddy CM. Prevalence of resistant hypertension and eligibility for catheter-based renal denervation in hypertensive outpatients. Am J Hypertens. 2013;26(12):1452\u20138.","journal-title":"Am J Hypertens"},{"issue":"3","key":"268_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/ajh\/hpu151","volume":"28","author":"D Achelrod","year":"2015","unstructured":"Achelrod D, Wenzel U, Frey S. Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations. Am J Hypertens. 2015;28(3):355\u201361.","journal-title":"Am J Hypertens"},{"issue":"13","key":"268_CR17","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","volume":"125","author":"SL Daugherty","year":"2012","unstructured":"Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, O\u2019Connor PJ, Selby JV, Ho PM. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. 2012;125(13):1635\u201342.","journal-title":"Circulation"},{"issue":"6","key":"268_CR18","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1161\/01.HYP.0000128420.01881.aa","volume":"43","author":"G. F. Mitchell","year":"2004","unstructured":"Mitchell GF, Parise H, Benjamin EJ, Larson MJ, Keyes MJ, Vita JA, Vasan RS, Levy D. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertens. (Dallas, Tex. 1979). 2004; 43(6):1239\u201345.","journal-title":"Hypertension"},{"key":"268_CR19","doi-asserted-by":"crossref","unstructured":"AlGhatrif M, Lakatta EG. The conundrum of arterial stiffness, elevated blood pressure, and aging. Curr Hypertens Rep. 2015;17(2):12.","DOI":"10.1007\/s11906-014-0523-z"},{"issue":"2","key":"268_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1161\/HYPERTENSIONAHA.114.03449","volume":"64","author":"GF Mitchell","year":"2014","unstructured":"Mitchell GF. Arterial Stiffness and Hypertension: chicken or Egg? Hypertension. 2014;64(2):210\u20134.","journal-title":"Hypertension"},{"issue":"5","key":"268_CR21","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1161\/01.HYP.36.5.801","volume":"36","author":"HD Sesso","year":"2000","unstructured":"Sesso HD, Stampfer MJ, Rosner B, Hennekens CH, Gaziano JM, Manson JE, Glynn RJ. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men. Hypertens (Dallas, Tex. 1979). 2000;36(5):801\u20137.","journal-title":"Hypertens (Dallas, Tex. 1979)"},{"issue":"16","key":"268_CR22","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/eurheartj\/ehs368","volume":"34","author":"DJ Kumbhani","year":"2013","unstructured":"Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC, Crowley K, Goto S, Ohman EM, Bakris GL, Perlstein TS, Kinlay S, Bhatt DL. Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. Eur Heart J. 2013;34(16):1204\u201314.","journal-title":"Eur Heart J"},{"issue":"11","key":"268_CR23","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1097\/00004872-200111000-00018","volume":"19","author":"C Cuspidi","year":"2001","unstructured":"Cuspidi C, Macca G, Sampieri L, Michev I, Salerno M, Fusi V, Severgnini B, Meani S, Magrini F, Zanchetti A. High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens. 2001;19(11):2063\u201370.","journal-title":"J Hypertens"},{"issue":"1","key":"268_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1161\/01.HYP.0000251933.22091.24","volume":"49","author":"G Mancia","year":"2007","unstructured":"Mancia G, Bombelli M, Corrao G, Facchetti R, Madotto F, Giannattasio C, Trevano FQ, Grassi G, Zanchetti A, Sega R. Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertens (Dallas, Tex. 1979). 2007;49(1):40\u20137.","journal-title":"Hypertens (Dallas, Tex. 1979)"},{"issue":"13","key":"268_CR25","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","volume":"125","author":"SL Daugherty","year":"2012","unstructured":"Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, O\u2019Connor PJ, Selby JV, Ho PM. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. 2012;125(13):1635\u201342.","journal-title":"Circulation"},{"issue":"4","key":"268_CR26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s40292-013-0022-3","volume":"20","author":"Franco Veglio","year":"2013","unstructured":"Veglio F, Grassi G, Mancia G, Volpe M, Italian Society of Hypertension. Clinical management of resistant hypertension: practical recommendations from the Italian Society of Hypertension (SIIA). High Blood Press Cardiovasc Prev. 2013;20(4):251\u20136.","journal-title":"High Blood Pressure & Cardiovascular Prevention"},{"issue":"2","key":"268_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/ajh\/hpw105","volume":"30","author":"T Dudenbostel","year":"2017","unstructured":"Dudenbostel T, Calhoun DA. Use of aldosterone antagonists for treatment of uncontrolled resistant hypertension. Am J Hypertens. 2017;30(2):103\u20139.","journal-title":"Am J Hypertens"},{"issue":"6","key":"268_CR28","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","volume":"40","author":"DA Calhoun","year":"2002","unstructured":"Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension. 2002;40(6):892\u20136.","journal-title":"Hypertension"},{"issue":"5","key":"268_CR29","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1517\/13543784.10.5.943","volume":"10","author":"SA Doggrell","year":"2001","unstructured":"Doggrell SA, Brown L. The spironolactone renaissance. Expert Opin Investig Drugs. 2001;10(5):943\u201354.","journal-title":"Expert Opin Investig Drugs"},{"issue":"11","key":"268_CR30","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","volume":"16","author":"M Nishizaka","year":"2003","unstructured":"Nishizaka MK, Zaman MA, Calhoun DA. Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens. 2003;16(11 I):925\u201330.","journal-title":"American Journal of Hypertension"},{"key":"268_CR31","doi-asserted-by":"crossref","unstructured":"Symplicity HTN-1 investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;57(5):911\u20137.","DOI":"10.1161\/HYPERTENSIONAHA.110.163014"},{"issue":"9756","key":"268_CR32","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","volume":"376","author":"MD Esler","year":"2010","unstructured":"Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, B\u00f6hm M, Mahfoud F, Sievert H, Wunderlich N, Rump LC, Vonend O, Uder M, Lobo M, Caulfield M, Erglis A, Azizi M, Sapoval M, Thambar S, Persu A, Renkin J, Schunkert H, Weil J, Hoppe UC, Walton T, Scheinert D, Binder T, Januszewicz A, Witkowski A, Ruilope LM, Whitbourn R, Bruck H, Downes M, L\u00fcscher TF, Jardine AG, Webster MW, Zeller T, Sadowski J, Bartus K, Straley CA, Barman NC, Lee DP, Witteles RM, Bhalla V, Massaro JM. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376(9756):1903\u20139.","journal-title":"Lancet"},{"issue":"15","key":"268_CR33","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","volume":"370","author":"DL Bhatt","year":"2014","unstructured":"Bhatt DL, Kandzari DE, O\u2019Neill WW, D\u2019Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL. A controlled trial of renal denervation for resistant hypertension. Nejm. 2014;370(15):1393\u2013401.","journal-title":"Nejm"},{"issue":"12","key":"268_CR34","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1161\/CIRCULATIONAHA.116.022922","volume":"134","author":"M Azizi","year":"2016","unstructured":"Azizi M, Pereira H, Hamdidouche I, Gosse P, Monge M, Bobrie G, Delsart P, Mounier-V\u00e9hier C, Courand PY, Lantelme P, Denolle T, Dourmap-Collas C, Girerd X, Michel Halimi J, Zannad F, Ormezzano O, Va\u00efsse B, Herpin D, Ribstein J, Chamontin B, Mourad JJ, Ferrari E, Plouin PF, Jullien V, Sapoval M, Chatellier G. Adherence to antihypertensive treatment and the blood pressure-lowering effects of renal denervation in the renal denervation for hypertension (DENERHTN) trial. Circulation. 2016;134(12):847\u201357.","journal-title":"Circulation"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40292-018-0268-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-018-0268-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-018-0268-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T23:14:25Z","timestamp":1561763665000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40292-018-0268-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,29]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["268"],"URL":"https:\/\/doi.org\/10.1007\/s40292-018-0268-x","relation":{},"ISSN":["1120-9879","1179-1985"],"issn-type":[{"value":"1120-9879","type":"print"},{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,29]]},"assertion":[{"value":"27 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the Ethics Committee for Clinical Research of the Provinces of Verona and Rovigo. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The 55 subjects who agreed to the inspection of their clinical records gave their informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}